The abstract is read at the publisher; the summary is JClub's.
Histological transformation is a key resistance mechanism in precision oncology, linked to tumor plasticity that can erode clinical benefit after initial success with targeted therapies.
- Why it matters: Targeted treatments can fail when tumors adapt through evolutionary changes, and understanding these processes is needed to design therapies that remain effective.
- What they did: This review synthesizes evidence on how tumor plasticity drives histological transformation during anticancer therapy and discusses strategies within precision oncology to counter it.
- The result: Leveraging cancer plasticity insights may help overcome histological transformation and improve patient outcomes, informing next-generation treatment approaches.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.